CANNALIFE PRESENTS, A MISFIT MANIFESTO: Lived Experience Is Knowledge. It Is Not Proof.
Observation is where science begins — and where good strategy often begins too.
There is a sentence people like to use when they want to end a conversation:
“That’s just anecdotal.”
Sometimes that is an important correction.
Sometimes it is intellectually lazy.
An anecdote is not a randomized controlled trial.
It is not proof of causation.
It cannot tell us whether something that happened once will happen again, whether another variable caused it or whether the person interpreting the experience understood what actually happened.
But anecdotal does not mean meaningless.
It means:
Someone noticed something.
And noticing something is often where inquiry begins.
Before the spreadsheet.
Before the protocol.
Before the statistical analysis.
Before the publication.
Someone usually says:
That’s interesting.
Then somebody else notices it too.
Then it happens again.
And eventually somebody asks the question science is built to answer:
Why?
a single Observation is not proof.
This distinction matters.
If I take something once and feel better afterward, I cannot conclude from that single experience alone that the thing caused my improvement.
Maybe it did.
Maybe something else changed.
Maybe I expected to feel better.
Maybe symptoms fluctuate naturally.
Maybe the dose mattered.
Maybe timing mattered.
Maybe another medication mattered.
Maybe ten other variables I never considered mattered.
That is precisely why controlled research exists.
Science gives us methods for separating:
what happened
from
what we think caused what happened.
These are different questions.
But observation is still information.
Here is where the conversation frequently goes off the rails.
We move from:
“An anecdote cannot prove causation.”
to:
“Therefore the anecdote is worthless.”
These are not the same statement.
If one patient reports an unexpected effect, we have a story.
If ten patients independently report something similar, we have an interesting observation.
If hundreds begin describing the same thing, we may have a pattern.
The pattern still does not prove the explanation.
But it may tell us that there is something worth investigating.
This is not anti-science.
This is often how science gets its questions.
People knew things before somebody published it
Not proved them.
Observed them.
Humans have always learned through observation.
Someone notices that a plant changes pain.
Someone notices that a particular food makes them sick.
Someone notices that symptoms appear after the same exposure.
Someone notices that certain patients respond differently than others.
Some of those observations eventually survive scientific scrutiny.
Some do not.
Some turn out to have been partially correct but explained incorrectly.
Some disappear completely once properly tested.
This is exactly the point.
Observation generates questions. Testing determines how much confidence we should place in the answer.
We do not need to choose between respecting experience and respecting evidence.
We need to stop confusing their jobs.
Lived experience is knowledge.
It just isn't the same kind of knowledge as controlled evidence.
A person living with chronic pain knows things about their pain that no laboratory instrument can directly tell you.
A person who has taken the same medication for ten years knows things about how that medication feels in their body.
A caregiver notices changes clinicians may never witness during a fifteen-minute appointment.
A cannabis patient may know that one product consistently feels different from another even when they cannot explain the pharmacology.
This knowledge matters.
But lived experience has boundaries too.
A patient can accurately report:
“Every time I do this, I experience that.”
They cannot automatically conclude:
“Therefore this biological mechanism caused it.”
That second question requires something different.
This, not that.
Experience describes the experience.
Research investigates the explanation.
Both belong in the conversation.
Cannabis makes this distinction impossible to ignore.
Cannabis patients spent decades observing effects while formal research was constrained by law, stigma and limited access to the plant itself.
People experimented with:
Dose.
Timing.
Route of administration.
Different products.
Different cultivars.
Ratios of cannabinoids.
Eating before use.
Not eating before use.
Using cannabis with other medications.
Using less.
Using more.
Stopping.
Starting again.
They were conducting uncontrolled experiments on themselves because, in many cases, nobody else was answering their questions.
History should not be romanticized.
People got things wrong.
Memory is imperfect.
Expectations influence perception.
Products were inconsistent.
Potency was often unknown.
Confounding variables were everywhere.
But dismissing all of those accumulated observations because they were not generated inside a controlled clinical trial would be equally foolish.
The responsible response is:
What are patients repeatedly telling us, and which of those observations deserve better investigation?
Anecdote and evidence are not enemies.
They sit in different places.
An anecdote tells us:
This happened to someone.
Repeated observations tell us:
This appears to be happening often enough that we should pay attention.
Observational research can tell us:
These variables appear to be associated under real-world conditions.
Controlled research can help us determine:
Does the relationship persist when we deliberately control competing explanations?
Accumulated evidence allows us to ask:
How confident should we be after considering the entire body of information?
Each layer answers a different question.
And business works remarkably similarly.
This is where the same principle becomes useful far outside medicine.
A customer hesitates at one point in the sales conversation.
Maybe nothing.
Another customer hesitates there.
Interesting.
Then another.
Then another.
The salesperson may continue calling each interaction unique.
The strategist starts counting.
Why does everybody hesitate on the same slide?
Why do buyers repeatedly ask the same question nobody predicted?
Why does the customer describe the problem differently than our marketing does?
Why does enthusiasm disappear immediately after pricing?
Why do people say price is the issue but behave as though trust is the issue?
That is observation.
And good strategy often begins there.
Customer behavior is data before somebody names it
Businesses love dashboards.
I love dashboards too.
But the spreadsheet only knows what someone decided to measure.
Human beings are generating information long before the analyst creates the column for it.
Your salespeople hear things.
Your customer-service team hears things.
Your clinicians notice things.
Your receptionist notices things.
Your customers do things nobody predicted when the strategy was built.
Somebody needs to notice.
Then ask:
Is this happening repeatedly?
Under what conditions?
With which customers?
What else might explain it?
How could we test it?
That sequence is not very different from scientific inquiry.
Observation.
Repeated observation.
Pattern.
Question.
Hypothesis.
Testing.
Measurement.
Adjustment.
Repeat.
Some people see patterns before there's a spreadsheet
That does not make them psychic.
It may simply mean they are paying attention to information other people discard.
Tone.
Timing.
Contradictions.
Repeated wording.
Small behavioral changes.
The question that always appears immediately before a deal stalls.
The complaint that seems unrelated until you've heard it twelve times.
The tiny inconsistency everyone else has normalized.
Different people notice different things.
Some neurodivergent people describe strengths involving pattern recognition, systems thinking, intense focus, detailed observation or noticing inconsistencies others miss.
Some do not.
Neurodivergence is not one brain type and it should not be turned into a romanticized superpower narrative. But different brains bring different strengths... as well as challenges.
The useful question is not:
Which brain is better?
It is:
What is this person noticing that the rest of us might be missing?
Pattern recognition can be powerful.
It can also fool us.
Human beings are extraordinarily good at finding patterns.
Sometimes too good.
We see faces in clouds.
Meaning in coincidence.
Causation in correlation.
Intent where there may only be randomness.
This is why noticing a pattern is the beginning of the process, not the end.
The first person to notice the pattern may not yet be able to prove it.
That does not mean the pattern is meaningless.
It means:
Now test it.
That is the difference between curiosity and certainty.
Curiosity says:
Something may be happening here.
Certainty says:
I already know why.
I trust the first one considerably more.
Great strategists notice what people say.
They also notice what people repeatedly do.
People tell you price matters most.
Then buy the more expensive option.
People tell you they want more information.
Then ignore the twelve-page brochure.
People say they trust the company.
Then hesitate before giving it their information.
People say a product is confusing.
Then describe exactly what they wish it did.
People are not necessarily lying.
Human behavior is complicated.
What we say, what we believe and what we ultimately do are not always perfectly aligned.
That discrepancy is information too.
A good strategist does not immediately announce:
“I know why.”
They ask:
“What could explain this?”
Then they go looking.
The danger is falling in love with the pattern.
This happens in science.
It happens in business.
It happens in healthcare.
It happens in relationships.
It happens everywhere humans think.
Once we notice something, we begin looking for confirmation.
Suddenly every new example appears to prove the theory.
Contradictory examples become exceptions.
Then the observation becomes belief.
The belief becomes identity.
And eventually evidence stops being something we use to test the idea.
It becomes something we selectively collect to defend it.
This is where curiosity dies.
So one of the most important questions we can ask ourselves is:
What evidence would make me change my mind?
If the answer is nothing, we are no longer investigating.
We are defending.
Experience counts.
Credentials count.
Neither is everything.
The false binary helps nobody.
The person with twenty years of lived experience may understand dimensions of a problem that the newly trained professional does not.
The trained professional may understand mechanisms, risks or evidence that lived experience alone cannot reveal.
The patient knows their body.
The scientist understands the study.
The clinician understands diagnosis and treatment.
The caregiver sees daily function.
The strategist sees behavioral patterns.
The statistician sees what our intuition missed.
Everybody has information.
Nobody automatically has all of it.
Good decisions happen when we stop asking which perspective gets to win and start asking:
What can this perspective legitimately teach or tell us?
This is the line.
Lived experience is knowledge.
It is not proof.
Anecdotes are information.
They are not controlled evidence.
Patterns are clues.
They are not conclusions.
Credentials are evidence of training.
They are not evidence of omniscience.
Science gives us tools for testing observations.
It does not require us to pretend observations never mattered.
And intuition can tell us where to look.
It cannot excuse us from looking.
Pay attention before you measure.
Then measure what you noticed.
That may be the bridge between science and strategy that interests me most.
Both begin with curiosity.
Someone notices something.
Someone asks why.
Someone refuses to dismiss the observation simply because the explanation is not yet known.
Then somebody does the harder work.
They investigate.
They test.
They measure.
They change their mind when the evidence requires it.
And sometimes they discover that the person who noticed the pattern first was right.
Sometimes they discover that person was completely wrong.
Both outcomes are useful.
Because the goal was never to protect the observation.
The goal was to understand what was actually happening.
Truth Is The Drug. All Warnings Ignored.
Jessica N. Humphreys, BSN Founder | CannaLife® | CannaLife MISFITS™ | MC Jazzi O™ | CannaLife Press™ | CannaRx™
I don't expect you'll agree with everything you read here.
But I do expect you'll at least think about it.
That's enough.
If this article made you think...
Share it.
Quote it.
Debate it.
Teach it.
Email it.
Text it to someone who needs to read it.
If you found value here, help someone else find it too.
Please keep my name attached and link back to the original article whenever you share it.
Because good ideas don't belong in echo chambers.
They belong in conversations.
Truth Is The Drug. All Warnings Ignored.
Jessica Humphreys, BSN
Founder | CannaLife® | CannaLife MISFITS™ | MC Jazzi O™ | CannaLife Press™ | CannaRx™
Comments